Brambles to exit India with $85m CHEP sale—find out why it’s a game-changer

Brambles to exit India with $85m CHEP sale—find out why it’s a game-changer

Brambles Limited, a leader in supply-chain logistics and pooling solutions, has entered into an agreement to sell its CHEP India business to LEAP India Private Limited for approximately INR 7,150 million (USD 85 million). This strategic sale marks Brambles’ exit from the Indian market and aligns with its disciplined capital allocation strategy. The transaction, which […]

Geotechnical work kicks off for NSW’s high-speed rail link to Sydney

Geotechnical work kicks off for NSW’s high-speed rail link to Sydney

Geotechnical work has commenced for the much-anticipated high-speed rail link between Sydney and Newcastle, marking the beginning of an ambitious infrastructure project set to reshape New South Wales’ transport landscape. This key development is a critical step towards delivering a faster and more efficient connection between Sydney and Newcastle, promising to bolster regional economies, reduce […]

Arthur J. Gallagher & Co. expands reach with acquisitions of Filos Agency, Via Financial Group, and Redington Ltd

Arthur J. Gallagher & Co. expands reach with acquisitions of Filos Agency, Via Financial Group, and Redington Ltd

Arthur J. Gallagher & Co. has solidified its position in the insurance and financial services markets by announcing three strategic acquisitions: New York-based Filos Agency, Australia’s Via Financial Group, and the UK’s Redington Ltd. These acquisitions reflect Gallagher’s aggressive growth strategy to broaden its portfolio across diverse geographies, from property/casualty insurance in the U.S. to […]

Arthur J. Gallagher expands with strategic acquisitions in Australia and UK

Arthur J. Gallagher expands with strategic acquisitions in Australia and UK

In a bid to strengthen its financial advisory footprint, Arthur J. Gallagher & Co. announced two key acquisitions, targeting firms with specialized financial expertise in Australia and the United Kingdom. The U.S.-based insurance giant acquired Sydney-based Via Financial Group Pty Ltd, known for its financial planning, wealth management, and life risk advisory services, alongside London-based […]

WiseTech CEO Richard White steps down amid scandal, shares rally

WiseTech CEO Richard White steps down amid scandal, shares rally

WiseTech Global, Australia’s premier logistics software giant, has witnessed a surprising resurgence in its share price following the announcement that its embattled CEO and founder, Richard White, would step down but continue as a consultant. The decision comes after a tumultuous period marked by allegations related to White’s personal conduct, causing shares to plummet earlier […]

TZ Limited announces acquisition of Keyvision to boost proptech capabilities

TZ Limited announces acquisition of Keyvision to boost proptech capabilities

TZ Limited, a leader in smart locker solutions, has announced a strategic acquisition aimed at expanding its proptech capabilities. The company entered a Heads of Agreement (HOA) to acquire Keyvision Holdings Pty Ltd, a high-margin proptech firm specializing in tenant experience apps. This acquisition is expected to significantly bolster TZ’s offerings in the residential, commercial, […]

Echo IQ’s EchoSolv AS gains FDA approval—AI-powered solution to tackle underdiagnosed Aortic Stenosis

Echo IQ’s EchoSolv AS gains FDA approval—AI-powered solution to tackle underdiagnosed Aortic Stenosis

Sydney-based AI medical technology company, Echo IQ Limited, has achieved a significant breakthrough with the US Food and Drug Administration (FDA) clearance for its EchoSolv AS software, positioning itself to transform Aortic Stenosis (AS) detection across the United States. This clearance not only permits the company to market its advanced solution in the United States […]

Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial

Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial

Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute Myelogenous Leukemia (AML) has exhibited a complete response following treatment in the CHM CORE-NK + Vactosertib Phase 1b trial. This achievement marks a cancer treatment innovation, highlighting immunotherapy progress and a significant cell therapy milestone. Chimeric Therapeutics, […]

Immutep completes patient enrolment for Phase II trial of eftilagimod alpha in metastatic breast cancer

Immutep completes patient enrolment for Phase II trial of eftilagimod alpha in metastatic breast cancer

Immutep Limited, a clinical-stage biotechnology company specializing in advanced LAG-3 immunotherapies, has announced the completion of patient enrolment for its Phase II AIPAC-003 clinical trial. This trial aims to assess the efficacy of its investigational agent, eftilagimod alpha (“efti”), in combination with the chemotherapy drug paclitaxel, for individuals with metastatic breast cancer. The trial has […]

Cokal Limited expands coal transport infrastructure to accelerate BBM production ramp-up

Cokal Limited expands coal transport infrastructure to accelerate BBM production ramp-up

In a strategic effort to enhance the ramp-up of BBM metallurgical coal production, Cokal Limited has significantly augmented its coal transport infrastructure by collaborating with PT Stanley Mitra Abadi, a local coal hauling contractor. This collaboration, coupled with the development of a semi-permanent steel bridge over the Mohing River, is anticipated to markedly improve coal […]

1 2 3 4